Cited by — When Earlier Is Better But Still Not Cost-Effective ― Reframing the Value of Tafamidis in Transthyretin Amyloid Cardiomyopathy ― | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite When Earlier Is Better But Still Not Cost-Effective ― Reframing the Value of Tafamidis in Transthyretin Amyloid Cardiomyopathy ―.
No admitted local citation edges point to this work yet.
